Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV003328158 | SCV001437607 | benign | CDH1-related diffuse gastric and lobular breast cancer syndrome | 2023-08-10 | reviewed by expert panel | curation | The NM_004360.4(CDH1):c.-124-161C>A variant has an allele frequency of 0.27733 (27.73%, 4262/15368 alleles, 578 homozygotes) in the European (Non-Finnish) subpopulation of the gnomAD v2.1.1 cohort (BA1; BP2). Therefore, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the CDH1 Variant Curation Expert Panel (Variant Interpretation Guidelines Version 3.1): BA1, BP2. |
Labcorp Genetics |
RCV001260567 | SCV001729141 | benign | Hereditary diffuse gastric adenocarcinoma | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001610289 | SCV001837256 | benign | not provided | 2018-06-23 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 23231047, 24491043, 11896626, 10706097, 24023817, 22792244, 17960397, 21997289, 19569232, 16189707, 22194161, 18781193, 21214416, 20462505, 17201188) |
Breakthrough Genomics, |
RCV001610289 | SCV005255427 | benign | not provided | criteria provided, single submitter | not provided | ||
OMIM | RCV004794334 | SCV000033279 | benign | Prostate cancer susceptibility | 2005-12-01 | no assertion criteria provided | literature only |